Time for clinically relevant comparative effectiveness studies in type 2 diabetes

Ann Intern Med. 2011 Jan 18;154(2):131-2. doi: 10.7326/0003-4819-154-2-201101180-00303. Epub 2010 Dec 6.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Comparative Effectiveness Research*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Exenatide
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use
  • Peptides / administration & dosage*
  • Peptides / adverse effects
  • Peptides / therapeutic use
  • Randomized Controlled Trials as Topic / standards
  • Research Design / standards
  • Venoms / administration & dosage*
  • Venoms / adverse effects
  • Venoms / therapeutic use

Substances

  • Hypoglycemic Agents
  • Peptides
  • Venoms
  • Exenatide